Methamphetamine-induced behavioral alterations following repeated administration of methamphetamine.
Repeated administration of a large dose of methamphetamine (MA) (25 mg/kg, i.p. twice daily for 4 days) to mice enhanced locomotor activity and decreased stereotyped behavior following a subsequent injection of MA. Simultaneous determinations of catecholamines revealed a depletion of brain dopamine. The moderate doses of haloperidol significantly enhanced MA-induced locomotor activity in mice. A significant enhancement of MA-induced locomotor activity was observed in the rats pretreated with 6-hydroxydopamine into the striatum, and this effect correlated negatively with the striatal dopamine level. These results suggest that hypofunction of striatal dopaminergic neuron systems induced by repeated administration of MA may be one of possible mechanisms of the enhancement of MA-induced locomotor activity due to the decrease of stereotyped behavior.
D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D003342:Corpus Striatum; D004347:Drug Interactions; D006220:Haloperidol / Q000494:pharmacology; D006892:Hydroxydopamines / Q000494:pharmacology; D007267:Injections; D008297:Male; D008694:Methamphetamine / Q000494:pharmacology*; D008728:Methotrimeprazine / Q000494:pharmacology; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D016627:Oxidopamine; D013239:Stereotyped Behavior / Q000187:drug effects*
D002395:Catecholamines; D006892:Hydroxydopamines; D008694:Methamphetamine; D016627:Oxidopamine; D008728:Methotrimeprazine; D006220:Haloperidol